Gut microbiome predictors of advanced therapy response in Crohn’s disease: protocol for the OPTIMIST prospective, longitudinal, observational pilot study in Canada
Cristian Aldo Massaro(University of British Columbia), Genelle Lunken(BC Children's Hospital), Yvette Leung(University of Calgary), Fanny Laure Lemarié(University of British Columbia), Brian Bressler(University of British Columbia), Gurpreet Kaur(Akal University), Susanna Meade(University of British Columbia), Astrid-Jane Williams, Greg Rosenfeld(British Columbia Centre on Substance Use)
Cited by 7
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478